Cinacalcet Shows Little Benefit in End-Stage Kidney DiseaseCinacalcet Shows Little Benefit in End-Stage Kidney Disease
Cinacalcet reduces the need for parathyroidectomy in a few patients with chronic kidney disease but appears to have no effect on all-cause or cardiovascular mortality and comes with adverse effects. Medscape Medical News
Source: Medscape Today Headlines - Category: Consumer Health News Tags: Nephrology News Source Type: news
More News: Cardiology | Cardiovascular | Chronic Kidney Disease | Health | Heart | Parathyroidectomy | Sensipar | Urology & Nephrology